Lynn L. Bergeson, “FDA Finds Current Regulatory Review Processes Protect Public from Risks of Nanomaterials,” Nanotechnology Now, October 29, 2013.

The U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) posted a blog item on October 24, 2013, concerning the use of nanotechnology to develop new drugs.